fiveGene	threeGene	source	drug	drugType	cancerType	level	hmfLevel	evidenceType	significance	hmfResponse
EGFR	KDD	oncoKb	Erlotinib	EGFR inhibitor	Non-Small Cell Lung Cancer	1	A	Predictive	Responsive	Responsive
EGFR	KDD	oncoKb	Afatinib	ERBB2 inhibitor;EGFR inhibitor	Non-Small Cell Lung Cancer	1	A	Predictive	Responsive	Responsive
EGFR	KDD	oncoKb	Gefitinib	EGFR inhibitor	Non-Small Cell Lung Cancer	1	A	Predictive	Responsive	Responsive
EML4	ALK	civic	Crizotinib	ALK inhibitor;MET inhibitor	Non-small Cell Lung Carcinoma	B	B	Predictive	Sensitivity	Responsive
